A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.
Lyons A, Kanesa-thasan N, Kuschner RA, Eckels KH, Putnak R, Sun W, Burge R, Towle AC, Wilson P, Tauber E, Vaughn DW.
Lyons A, et al. Among authors: burge r.
Vaccine. 2007 Apr 30;25(17):3445-53. doi: 10.1016/j.vaccine.2006.12.046. Epub 2007 Jan 4.
Vaccine. 2007.
PMID: 17241714
Clinical Trial.